Treatment of Parkinson’s disease psychosis
Journal Title: Medicina Internacia Revuo - Year 2017, Vol 27, Issue 109
Abstract
Early in the course of Parkinson disease (PD), treatment usually goes well. However, after five to ten years, things start to change as treatment requires higher doses of medications and side effects become more problematic. One of the most difficult problems is the development of hallucinations or delusions. Throughout the 20th century, treatment options were unproven and unsatisfactory, but the past 20 years have brought important changes. Two medications that are well tolerated in PD have now proved efficacious in randomized, controlled trials, and others are in development. Here I summarize this history briefly and provide a general plan for treating the patient with PD complicated by psychotic symptoms.
Authors and Affiliations
Kevin Black
Keywords
Related Articles
- EP ID EP382070
- DOI -
- Views 62
- Downloads 0
Changes in pharmacokinetic properties of drugs in critically ill patients – Part I
The essential and the most difficult goal for the implementation of pharmacotherapy in critically ill patients is to achieve the desired pharmacological effect, while minimizing side effects of drugs. The desired pharmac...
Treatment planning of complicated endodontic cases with the use of CBCT
Including assessing dental morphology prior to endodontic treatment, locating tooth perforations, separated endodontic files, and resorptions. The aim of this paper was to present the usefulness of CBCT in endodontic tre...
Treatment of Parkinson’s disease psychosis
Early in the course of Parkinson disease (PD), treatment usually goes well. However, after five to ten years, things start to change as treatment requires higher doses of medications and side effects become more problema...
Antidepressant-like and anxiolytic-like activity of a novel indole amine derivative ADN-2013 in rodents
A novel indolamine derivative, ADN-2013, has been proved to possess a preclinical activity pro le appropriate for the treatment of behavioral and psychological symptoms of dementia. Its antidepressant and anxiolytic prop...
Evaluation of anti-manic activity of pregabalin in a mouse model of methylphenidate-induced mania
Mania is a psychiatric disorder which may occur alternately with depression as a bipolar disorder, or much less often as an individual disease. It might be accompanied by other disorders, i.e. schizophrenia, dementia or...